Difficulty: Medium
Average Score: 80%
Practice
Hydroxyethyl starches
Correct answer
C
Rationale
In the context of CNS stimulants drugs pharmacology, understanding the characteristics of hydroxyethyl starches is crucial for healthcare professionals. The correct answer, option C, states that hydroxyethyl starches can precipitate renal failure. This is because these starches have been associated with renal toxicity, especially in patients with pre-existing renal impairment. They can cause renal failure by inducing osmotic nephrosis, leading to impaired kidney function.
Option A, stating that hydroxyethyl starches are allergenic, is incorrect. While allergic reactions can occur with any substance, the primary concern with hydroxyethyl starches lies in their potential for renal toxicity, not allergenicity.
Option B, claiming that hydroxyethyl starches do not cause coagulation disturbances, is also incorrect. These starches have been associated with coagulopathy, particularly in high doses or in patients with specific risk factors. They can interfere with platelet function and clotting factors, leading to coagulation disturbances.
Option D, suggesting that hydroxyethyl starches are hydrolyzed by amylase, is incorrect. Hydroxyethyl starches are not metabolized by human enzymes like amylase. Instead, they are broken down in the body through different mechanisms, including renal excretion and degradation by plasma amylase.
In an educational context, understanding the pharmacological properties of hydroxyethyl starches is essential for healthcare providers who may encounter these drugs in clinical practice, particularly in settings where fluid resuscitation or volume expansion is required. Awareness of their potential renal and coagulation risks can guide appropriate prescribing and monitoring practices to ensure patient safety.
Option A, stating that hydroxyethyl starches are allergenic, is incorrect. While allergic reactions can occur with any substance, the primary concern with hydroxyethyl starches lies in their potential for renal toxicity, not allergenicity.
Option B, claiming that hydroxyethyl starches do not cause coagulation disturbances, is also incorrect. These starches have been associated with coagulopathy, particularly in high doses or in patients with specific risk factors. They can interfere with platelet function and clotting factors, leading to coagulation disturbances.
Option D, suggesting that hydroxyethyl starches are hydrolyzed by amylase, is incorrect. Hydroxyethyl starches are not metabolized by human enzymes like amylase. Instead, they are broken down in the body through different mechanisms, including renal excretion and degradation by plasma amylase.
In an educational context, understanding the pharmacological properties of hydroxyethyl starches is essential for healthcare providers who may encounter these drugs in clinical practice, particularly in settings where fluid resuscitation or volume expansion is required. Awareness of their potential renal and coagulation risks can guide appropriate prescribing and monitoring practices to ensure patient safety.